HEXO is strengthening its commitment towards research and innovation by appointing Veronique Hamel as its Chief Innovation Officer. With global experience in new product development Ms. Hamel is well positioned to develop research strategy and oversee HEXO’s research and innovation pipeline.
“I am pleased to welcome Veronique to our leadership team,” said HEXO’s CEO and co-founder, Sebastien St-Louis. “Veronique has a track record for building and helping shape high growth and consumer-centric organizations through trusted and award-winning innovations. She brings a strong business acumen to the process of innovation as well as a passion for break-throughs and industry firsts.”
Throughout her career spanning over 25 years, Veronique Hamel has developed expertise in innovation through leadership roles in research and development, new product development, marketing, and business development for global consumer goods and pharmaceutical companies in Europe, the U.S. and Canada.
Most recently, Veronique has built strong, innovative teams in Canada at Church & Dwight Canada, Bausch & Lomb and Bausch Health Companies Inc.
“I am proud to join the competent team at HEXO,” said Veronique Hamel. “HEXO has already shown extraordinary commitment to quality and innovation and has been recognized for that. I am thrilled to be on board to expand the Company’s innovation footprint and bring exciting, new and trusted solutions to consumers.”
Veronique Hamel is a graduate from EDHEC Business school in France.
For more information:
HEXO
www.hexocorp.com